← All Si-bone, INC filings

Si-bone, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
SIBN
Si-bone, INC
SCHEDULE: Cadian Capital Management Discloses SI-BONE Stake
Cadian Capital Management, LP, along with its affiliates, has reported beneficial ownership of approximately 7.5% of SI-BONE, Inc.'s common stock as of June 30, 2026.
NASDAQ
SIBN
Si-bone, INC
SCHEDULE: First Light Asset Management Discloses SI-BONE Stake
First Light Asset Management, LLC and Mathew P. Arens have jointly filed a Schedule 13G, reporting beneficial ownership of 18.02% and 18.36% of SI-BONE, Inc. common stock, respectively.
NASDAQ
SIBN
Si-bone, INC
SCHEDULE: Vanguard Group Exits SI-BONE Stake After Internal Realignment
The Vanguard Group reported zero beneficial ownership in SI-BONE Inc. common stock following an internal realignment effective January 12, 2026.
NASDAQ
SIBN
Si-bone, INC
SCHEDULE: American Century Funds Disclose Si-Bone Stake
American Century Mutual Funds, Investment Management, and related entities reported beneficial ownership of 5.3% of Si-Bone, Inc.'s common stock as of December 31, 2025.
NASDAQ
SIBN
Si-bone, INC
SCHEDULE: Brown Advisory Discloses 5.79% Stake in SI-BONE
Brown Advisory and its affiliates have reported a 5.79% beneficial ownership stake in SI-BONE, Inc. common stock as of December 31, 2025.
NASDAQ
SIBN
Si-bone, INC
SCHEDULE: Champlain Investment Partners Discloses 4.9% Stake in SI-BONE
Champlain Investment Partners, LLC has reported a 4.9% beneficial ownership stake in SI-BONE, Inc. as an investment adviser.
NASDAQ
SIBN
Si-bone, INC
SCHEDULE: First Light Asset Management Boosts SI-BONE Stake
First Light Asset Management and Mathew P. Arens report beneficial ownership of 11.92% of SI-BONE, Inc.'s common stock.
NASDAQ
SIBN
Si-bone, INC
SCHEDULE: American Century Group Amends Si-Bone Stake to 6.6%
American Century Investment Management, along with its affiliates, has updated its beneficial ownership in Si-Bone, Inc. to 6.6% of common stock as of September 30, 2025.
NASDAQ
SIBN
Si-bone, INC
SCHEDULE: OrbiMed Discloses 6% Stake in SI-BONE Inc.
OrbiMed Capital LLC and OrbiMed Advisors LLC have disclosed a combined 6.0% beneficial ownership stake in SI-BONE, Inc. common stock.
NASDAQ
SIBN
Si-bone, INC
SCHEDULE: Champlain Investment Partners Discloses 5% Stake in SI-BONE
Champlain Investment Partners, LLC has disclosed a 5.0% beneficial ownership stake in SI-BONE, Inc. common stock as of June 30, 2025.
NASDAQ
SIBN
Si-bone, INC
SCHEDULE 13G/A: OrbiMed Entities Amend SI-BONE Stake, Disclosing 8.1% Aggregate Passive Ownership
OrbiMed Capital LLC and OrbiMed Advisors LLC have filed an amendment to their Schedule 13G, collectively reporting an 8.1% beneficial ownership stake in SI-BONE, Inc. as of March 31, 2025.
NASDAQ
SIBN
Si-bone, INC
SCHEDULE 13G/A: American Century Investment Management Discloses 6.2% Passive Stake in Si-Bone, Inc.
American Century Investment Management, along with its affiliates, has disclosed a 6.2% passive ownership stake in Si-Bone, Inc. as of March 31, 2025.
NASDAQ
SIBN
Si-bone, INC
SCHEDULE 13G/A: Brown Advisory Group Discloses 7.6% Stake in SI-BONE, Inc. Common Stock
Brown Advisory Inc. and its subsidiaries have filed an amended Schedule 13G, reporting a collective beneficial ownership of 7.6% of SI-BONE, Inc.'s common stock as of March 31, 2025.
NASDAQ
SIBN
Si-bone, INC
SCHEDULE 13G/A: BlackRock Maintains Significant 8.1% Stake in SI-BONE, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, confirming its beneficial ownership of 8.1% of SI-BONE, Inc.'s common stock as of March 31, 2025.